| Dr Ira Strassman, MD | |
|
250 West Lancaster Ave, Suite 340, Paoli, PA 19301 | |
| (610) 407-9000 | |
| (610) 407-9005 |
| Full Name | Dr Ira Strassman |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 250 West Lancaster Ave, Paoli, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285657767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD-043367-L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ira Strassman, MD 250 West Lancaster Ave, Suite 340, Paoli, PA 19301 Ph: (610) 407-9000 | Dr Ira Strassman, MD 250 West Lancaster Ave, Suite 340, Paoli, PA 19301 Ph: (610) 407-9000 |
News Archive
A brain network linked to introspective tasks - such as forming the self-image or understanding the motivations of others - is less intricate and well-connected in children, scientists at Washington University School of Medicine in St. Louis have learned.
The Senate Appropriations Committee on Thursday voted 26-3 to approve a $152 billion fiscal year 2008 Labor-HHS-Education appropriations bill after the addition of an amendment that would expand federal funding for embryonic stem cell research, CongressDaily reports (Cohn, CongressDaily, 6/22).
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced data from a preclinical study on the erythropoietin (EPO) receptor agonist LG5640 at the upcoming 52nd American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4 - 7, 2010.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.
› Verified 7 days ago
Rand E Kienzle, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11 Industrial Blvd Ste 201, Paoli, PA 19301 Phone: 610-647-1484 Fax: 610-647-7068 | |
Mary Anita Dilloway, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 255 W Lancaster Ave, Mob 1 Ste 101, Paoli, PA 19301 Phone: 610-644-9380 Fax: 610-644-4872 | |
Dr. Anne Rosato, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 250 West Lancaster Ave, Suite 340, Paoli, PA 19301 Phone: 610-407-9000 Fax: 610-407-9005 | |
G. Edward Kienzle, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 17 Industrial Blvd, Suite 204, Paoli, PA 19301 Phone: 610-647-1484 Fax: 610-647-7068 | |
Dr. Eileen Elizabeth Tyrala, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 610-334-8341 Fax: 610-649-4735 | |
Dr. Sandra Jean Becker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 315 Continental Ln, Paoli, PA 19301 Phone: 610-296-1238 Fax: 610-296-1238 |